You just read:

Regen BioPharma Initiates NR2F6 T Cell Immunotherapy Preclinical Program with Dr. Santosh Kesari, Director of Neuro-oncology at John Wayne Cancer Institute

News provided by

Regen BioPharma Inc.

Nov 12, 2015, 08:30 ET